High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. - Wikidata - awgldk - TriplyDB

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

http://www.wikidata.org/entity/Q36175681

about

Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review Emerging role of Toll-like receptor 4 in hepatocellular carcinoma Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival Trauma equals danger--damage control by the immune system Potential role of High mobility group box 1 in hepatocellular carcinoma Role of receptor for advanced glycation end products (RAGE) in liver disease Mechanisms linking excess adiposity and carcinogenesis promotion Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.HMGB1 in health and disease.Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression.The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9 Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death.Life after death: targeting high mobility group box 1 in emergent cancer therapies.Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells.HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2 Many faces of DAMPs in cancer therapy.Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes.Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro.HMGB1 in cancer: good, bad, or both?Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury.The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.

P2860

Q26738966-096CCA97-7F0A-4FB8-9838-8F8263D266D2 Q26746478-7E2FF46F-F66E-433C-BB44-1E016CA6CE76 Q26765594-C6D8C6E1-33BC-4B56-91CC-596DD3756F3C Q26770029-E5D2E56B-4F4A-4C3D-83E6-47AB6170F663 Q26781477-9715BFB7-703E-4A21-8491-78DAA61E3B2E Q26782281-C8AD92AA-577F-49E5-BC54-BD4477387D2E Q26824613-FA50F508-E228-4DB3-8838-ECDC0C326DA1 Q26853543-0C19A9E3-65DA-4CEE-B7E6-29C5F4807094 Q26860731-A23E26D9-EEF6-41CA-91CB-7B8ADA14FE54 Q26864508-ECE5F8ED-245F-42D8-84C9-47BC2A6A0A1B Q27010462-C456B12E-4C3B-4C2F-A443-81F9424C4F2D Q27022929-8530DC60-6011-4230-8BC8-513AB0EE632D Q27325462-94F83163-AF84-4318-A031-2273160E79F9 Q28384683-E8F7ACBD-ABBD-410C-8B71-FF865CF0DB15 Q28830568-16158956-D1DD-4C75-9F72-9840AE720400 Q33914305-73588386-3941-4AB4-90C5-2E356D71F669 Q34214279-51136BA4-17D8-48B4-ACCA-461ACF9924A2 Q34428389-EFC1D15F-7B41-4C5B-B147-F671911F5633 Q34622835-12BBC8C4-2A98-4580-9907-94A68737E2CF Q35025037-347C3568-34D7-4CA9-BC86-B64683AE2CF9 Q35136610-6056FA00-71AC-41F1-A44E-31B7E8F3FCFF Q35463638-2BACB77A-46B1-4287-8001-852FF3BBD6FB Q35523700-DE533DC5-9E76-4FC9-86EA-A912DF99636D Q35762937-F6C900B6-B3E8-4D6C-A2F4-77A594C6D016 Q35913266-EB6BB73D-BE87-4F36-8EB9-3338CBC6A004 Q36153175-C1C53E30-397B-489C-8590-ACB5F7009F08 Q36190325-9CD27C66-915B-4A56-8EDC-F34D18E3F77F Q36261535-4BC84F9E-E2F0-4501-AA30-4B1A0E2624B6 Q36265872-FA3848CD-B958-4C79-9898-D42246A8D7ED Q36562901-48D444D1-5AA4-4AE4-ABED-AB7CE9832D10 Q36674083-22331C41-8524-4ADC-B8A2-9C4FD9A1ACF7 Q36834531-EF9BA5CB-ED36-4201-A478-B22AFE9E2052 Q36907117-C17D5CD6-28A9-4FB0-8B4E-2CF4FDA2FC38 Q36918035-0171E92C-4A8E-48FD-BE1A-6DFD574B3ED9 Q36985164-9D657B22-CCE0-4F7A-A48A-55EA2F0E136E Q36997263-E8240679-D2E2-4484-951D-96DFDEB2C5E7 Q37067481-6D748145-0E19-4495-A688-26AF4957DE63 Q37182947-4A88C32E-A64B-4FBF-B8CA-7714EB683BA8 Q37190352-4BBDB7E6-D12D-4AE9-AF67-BCAC96791641 Q37305013-9FD171D2-B6C2-4817-B752-FE82FBBF16AE

P2860

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

http://www.wikidata.org/entity/Q36175681

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

High-mobility group box 1 acti ...... a invasiveness and metastases.

@ast

High-mobility group box 1 acti ...... a invasiveness and metastases.

@en

type

label

High-mobility group box 1 acti ...... a invasiveness and metastases.

@ast

High-mobility group box 1 acti ...... a invasiveness and metastases.

@en

prefLabel

High-mobility group box 1 acti ...... a invasiveness and metastases.

@ast

High-mobility group box 1 acti ...... a invasiveness and metastases.

@en

P1433

Q36175681-63D5C40E-B3C0-4CEC-B3A0-D21947CC3F75

P1476

Q36175681-69750B1F-C4F9-4F2B-8EBC-7FC7B546F6F2

P2093

Q36175681-28547620-8599-4AA1-A790-3330B8D5908C

Q36175681-507845C0-F99C-4A0D-B907-514A65BA388A

Q36175681-74E75930-D0AD-475D-AEF6-8367862FC896

Q36175681-77CD56D0-4401-4477-9424-26A430958ED6

Q36175681-865E95C8-83BD-4909-9FE2-099A771FEAB2

Q36175681-9CF28265-3117-4A22-8B05-B748207E4C81

Q36175681-9D8494E3-754B-4DD1-A46B-D82F179A27AC

Q36175681-AA36B2E1-2FF3-4BD9-87C6-08CE7F7C8D98

Q36175681-B865ECF8-94B2-4299-8860-AA88F5AB4BF0

Q36175681-E1F2AE29-4BFD-48D1-9D3B-945FA82BC6CC

P2860

Q36175681-0419CD0A-018C-4D24-8877-F394C6ED7E58

Q36175681-0A1F7AD9-2089-48F0-B499-FE8AE928AD16

Q36175681-1698A372-BBC0-422B-8088-28BF29E838B1

Q36175681-2634F71C-FCB5-42AE-B203-A45AC2C127C7

Q36175681-26AFAB42-481F-42B1-86FA-B961DAC421BB

Q36175681-31175ED6-8DBA-45D3-9D6A-44BE82FFDFE3

Q36175681-3500D964-1B8D-4F8B-88E0-D32C43B735D4

Q36175681-3B124FFD-EE69-4C6B-A730-98663ED8C4DF

Q36175681-47A7EDEF-D0D7-4EFF-AC06-D072F8FFA302

Q36175681-4DCF4977-AD6E-4459-9E6E-0BD31553731A

P304

Q36175681-3A33A3CE-18F3-4466-B411-48FECDAC3F62

P31

Q36175681-66639161-88D8-43A3-8BC7-BF3EA8D27B5E

P356

Q36175681-43925604-2C62-4C85-BF14-7C570160B10B

P407

Q36175681-E9DFBC17-8C93-40B1-9BB1-A30CCCE226CB

P433

Q36175681-5EB69099-A156-4FC2-819A-AB34E4631F9F

P478

Q36175681-CC270106-1B75-4CBA-855D-4160827D8A06

P577

Q36175681-710C6774-DF20-4A9D-BC0B-0099E4CE7995

P5875

Q36175681-4D637F78-C149-41F8-8756-1C8543230A22

P698

Q36175681-E32F8A31-5ABA-478A-996F-AF0058BE4C54

P932

Q36175681-DAD98C25-5081-4F14-9BD2-F9AE6EC50007

P356

P1433

P1476

High-mobility group box 1 acti ...... a invasiveness and metastases.

@en

P2093

Allan Tsung

http://www.w3.org/2001/XMLSchema#string

David A Geller

http://www.w3.org/2001/XMLSchema#string

Hai Huang

http://www.w3.org/2001/XMLSchema#string

Jon S Cardinal

http://www.w3.org/2001/XMLSchema#string

Michael T Lotze

http://www.w3.org/2001/XMLSchema#string

Satdarshan P S Monga

http://www.w3.org/2001/XMLSchema#string

Stephen H Thorne

http://www.w3.org/2001/XMLSchema#string

Wei Yan

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Liang

http://www.w3.org/2001/XMLSchema#string

Ying Chang

http://www.w3.org/2001/XMLSchema#string

P2860

The inflammasomes

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

HMGB1 and RAGE in inflammation and cancer

NF-kappaB: linking inflammation and immunity to cancer development and progression

The inflammasome NLRs in immunity, inflammation, and associated diseases

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

High-mobility group box 1 and cancer.

Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta

Analysis and verification of the HMGB1 signaling pathway.

P304

1863-1875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.25572

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221738304

http://www.w3.org/2001/XMLSchema#string

P698

22234969

http://www.w3.org/2001/XMLSchema#string

P932

4610360

http://www.w3.org/2001/XMLSchema#string